In addition to the cGMP production of recombinant proteins, Novartis is offering master cell bank and working cell bank manufacturing.
A master cell bank is key for the product development and manufacture of protein and nucleic acid based products. It is the foundation for clinical development and manufacturing, and also for commercial production. A working cell bank is generated from the master cell line for further scale up in production and to guarantee high quality.
- cGMP preparation of master and working cell banks
- Highly experienced team
- Release testing according to current guidelines
- State-of-the-art storage facilities
With several decades of experience Novartis can offer high quality cell bank manufacturing to its customers.